Legal NewsRoom
Menu
Menu
LEGAL NEWS
HOT TOPICS
LexisNexis® Legal Newsroom
ACA and Healthcare Reform
Antitrust and Unfair Competition
Banking and Finance
Bankruptcy
California
Climate Change
Constitutional Law and Civil Rights
Consumer Protection & Privacy
Contracts and Commercial Law
Corporate
Criminal Law and Procedure
Energy
Environmental
Estate and Elder Law
Family Law
Financial Fraud Law
Florida
Fracking and Alternative Energy
Health Care
Hot Topics
Hurricane Sandy
Illinois
Immigration Law
Immigration Reform
Insurance Law
Intellectual Property
International Law
International Trade
Labor and Employment Law
Law360
Legal Business
Lexis® Hub
Litigation
Mealeys
Media and Entertainment
Mergers and Acquisitions
New Jersey
New York
Pennsylvania
Public Contracts
Public media
Public Policy
Real Estate Law
Securities
Sports Law
Tax Law
Technology
Texas
Top Emerging Trends
Torts
Virtual Currency
Workers' Compensation
NEWS & INSIGHT
Blogs and Newsletters
BIZ Blog
Blog Mosaic
Business of Law Blog
Corporate Law Advisory
Legal Content Insider
LexTalk
State Net
®
Capitol Journal
News & Trending Topics
Law360
Legal Insights & Trends
Lexis Practice Advisor Journal
Professional Communities
Business Insight Solutions – Partner Portal
Corporate InfoPro (Corporate Information Professionals)
InfoPro (Legal Information Professionals)
LexisNexis
®
for Developers
Litigators Verdict & Settlement Exchange
VISIT LEXISNEXIS LEGAL & PROFESSIONAL
Search
Search
Please enter a Keyword
This should not be used for legal research but instead can be used to find solutions that will help you do legal research.
Sign In
Browse By Tags
antipsychotic drug
Consumer Credit and Protection Act
Darrell V. McGraw Jr.
Dear Health Care Professional
DHCP
diabetes
Duragesic
FDA
fentanyl
Food and Drug Administration
Janssen Pharmaceutical Products
Johnson & Johnson
Judgment
lawsuit
Litigation
personal injury
product liability
Risperdal
skin patch
State of West Virginia v. Johnson & Johnson
torts
West Virginia Supreme Court of Appeals
Tom Moylan
over 12 years ago
Litigation
Litigation Blog
West Virginia High Court Vacates $4.47M Judgment; FDA Warning Letters Not Matter Of Law
CHARLESTON, W.Va. -- (Mealey's) The West Virginia Supreme Court of Appeals on Nov. 18 reversed a $4,475,000 consumer law judgment against Johnson & Johnson concerning the marketing of Risperdal and Duragesic after agreeing with the defendant that...